Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AstraZeneca grants Seroquel rights to Luye Pharma

Executive Summary

AstraZeneca PLC granted Luye Pharma Group Ltd. rights to sell its schizophrenia and bipolar disease treatment Seroquel/Seroquel XR (quetiapine) in the UK, China, Brazil, Australia, Saudia Arabia, Mexico, South Korea, Thailand, Argentina, Malaysia, South Africa, and a number of other international countries.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies